{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:21:22Z","timestamp":1771510882550,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Roche Diabetes Care, Netherland and Spain","award":["Eversense materials were made available by Roche D"],"award-info":[{"award-number":["Eversense materials were made available by Roche D"]}]},{"name":"Bas van de Goor foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,6,27]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Accurate blood glucose measurements are important in persons with diabetes during normal daily activities (NDA), even more so during exercise. We aimed to investigate the performance of fluorescence sensor-based and glucose oxidase-based interstitial glucose measurement during (intensive) exercise and NDA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>Prospective, observational study in 23 persons with type 1 diabetes when mountain biking for 6\u2009days, followed by 6\u2009days of NDA. Readings of the Eversense (fluorescence-based continuous glucose monitoring (CGM); subcutaneously implanted) and of the Free Style Libre (FSL; glucose oxidase-based flash glucose monitoring (FGM); transcutaneously placed) were compared with capillary glucose levels (Free Style Libre Precision NeoPro strip (FSLCstrip)).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Mean average differences (MAD) and mean average relative differences (MARD) were significantly different when comparing exercise with NDA (reference FSLCstrip); Eversense MAD 25\u00b119 vs 17\u00b16\u2009mg\/dL (p&lt;0.001); MARD 17\u00b16\u2009vs 13%\u00b16% (p&lt;0.01) and FSL MAD 32\u00b117 vs 18\u00b18\u2009mg\/dL (p&lt;0.01); MARD 20\u00b17\u2009vs 12%\u00b15% (p&lt;0.001).<\/jats:p>\n                  <jats:p>When analyzing the data according to the Integrated Continuous Glucose Monitoring Approvals (class II\u2013510(K) guidelines), the overall performance of interstitial glucose readings within 20% of the FSLCstrip during exercise compared with NDA was 69% vs 81% for the Eversense and 59% vs 83% for the FSL, respectively. Within 15% of the FSLCstrip was 59% vs 70% for the Eversense and 46% vs 71% for the FSL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>During exercise, both fluorescence and glucose oxidase-based interstitial glucose measurements (using Eversense and FSL sensors) were less accurate compared with measurements during NDA. Even when acknowledging the beneficial effects of CGM or FGM, users should be aware of the risk of diminished accuracy of interstitial glucose readings during (intensive) exercise.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001193","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T09:43:13Z","timestamp":1597138993000},"page":"e001193","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-1157","authenticated-orcid":false,"given":"Marion","family":"Fokkert","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry, Isala, Zwolle, NA, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-6551","authenticated-orcid":false,"given":"Peter R","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"},{"name":"Diabetes Research Center, Isala, Zwolle, NA, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-5035","authenticated-orcid":false,"given":"Mireille A","family":"Edens","sequence":"additional","affiliation":[{"name":"Department Innovation and Science, Isala, Zwolle, NA, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"D\u00edez Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Endocrinolog\u00eda, Hospital del Bierzo, Ponferrada, Castilla y Le\u00f3n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert","family":"Slingerland","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Isala, Zwolle, NA, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rijk","family":"Gans","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-9712","authenticated-orcid":false,"given":"El\u00edas","family":"Delgado \u00c1lvarez","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Diabetes, Universidad de Oviedo, Oviedo, Asturias, Spain"},{"name":"Secci\u00f3n de Diabetes, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"Bilo","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Isala, Zwolle, NA, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2025073113184514000_8.1.e001193.1","first-page":"425","article-title":"Physical excercises on glycemic control in type 1 diabetes mellitus","volume":"26","author":"Lopes Souto","year":"2011","journal-title":"Nutr Hosp"},{"key":"2025073113184514000_8.1.e001193.2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i3.534"},{"key":"2025073113184514000_8.1.e001193.3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40279-015-0379-7","article-title":"In search of the ideal resistance training program to improve glycemic control and its indication for patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"46","author":"Ishiguro","year":"2016","journal-title":"Sports Med"},{"key":"2025073113184514000_8.1.e001193.4","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815603528"},{"key":"2025073113184514000_8.1.e001193.5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s40618-016-0495-8","article-title":"Head-To-Head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes","volume":"39","author":"Bonora","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"2025073113184514000_8.1.e001193.6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/dom.12907","article-title":"Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes","volume":"19","author":"Aberer","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2025073113184514000_8.1.e001193.7","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010093","article-title":"Interstitial glucose and physical exercise in type 1 diabetes: integrative physiology, technology, and the gap In-Between","volume":"10","author":"Moser","year":"2018","journal-title":"Nutrients"},{"key":"2025073113184514000_8.1.e001193.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000320"},{"key":"2025073113184514000_8.1.e001193.9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/dme.14259","article-title":"Performance of continuous glucose monitoring devices during intensive exercise conditions in people with diabetes: the Mont blanc experience","volume":"37","author":"Fokkert","year":"2020","journal-title":"Diabet Med"},{"key":"2025073113184514000_8.1.e001193.10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3390\/s17081866","article-title":"Glucose sensing for diabetes monitoring: recent developments","volume":"17","author":"Bruen","year":"2017","journal-title":"Sensors"},{"key":"2025073113184514000_8.1.e001193.11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jfda.2014.12.001","article-title":"Recent developments in blood glucose sensors","volume":"23","author":"Wang","year":"2015","journal-title":"J Food Drug Anal"},{"key":"2025073113184514000_8.1.e001193.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2014.05.022"},{"key":"2025073113184514000_8.1.e001193.13","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1525"},{"key":"2025073113184514000_8.1.e001193.14","doi-asserted-by":"crossref","DOI":"10.3390\/bios8010022","article-title":"Accuracy of continuous glucose monitoring before, during, and after aerobic and anaerobic exercise in patients with type 1 diabetes mellitus","volume":"8","author":"Biagi","year":"2018","journal-title":"Biosensors"},{"key":"2025073113184514000_8.1.e001193.15","unstructured":"T\u00fcVRheinland . Goedgekeurde bloedglucosemeters, 2019. Available: https:\/\/www.tuv.com\/nl\/netherlands\/services_nl\/product_testing_nl\/medical_devices_nl\/tested_medical_device.html"},{"key":"2025073113184514000_8.1.e001193.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015485"},{"key":"2025073113184514000_8.1.e001193.17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/dia.2018.0142","article-title":"A new era in continuous glucose monitoring: food and drug administration creates a new category of Factory-Calibrated Nonadjunctive, Interoperable class II medical devices","volume":"20","author":"Garg","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2025073113184514000_8.1.e001193.18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1143"},{"key":"2025073113184514000_8.1.e001193.19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/dia.2018.0364","article-title":"Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes","volume":"21","author":"Zaharieva","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2025073113184514000_8.1.e001193.20","unstructured":"Baillie Lab . Altitude air pressure calculator. Available: https:\/\/baillielab.net\/critical_care\/air_pressure\/"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:18:52Z","timestamp":1753993132000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/bmjdrc-2020-001193"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001193","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}